Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader Guide, Feedback, and Issue Reporting
timothy sykes logo

Stock News

Lantheus Holdings Pushes Forward with Big Acquisition

Jack KelloggAvatar
Written by Jack Kellogg Reviewed by Tim Sykes Fact-checked by Ellis Hobbs
Updated 2/26/2025, 2:32 pm ET 6 min read
Lantheus Holdings Pushes Forward with Big Acquisition Thumbnail

Lantheus Holdings Inc.’s stock received a strong boost this Wednesday after reports highlighted its promising advancements in medical imaging technology, leading to increased market confidence and anticipation of further growth. On Wednesday, Lantheus Holdings Inc.’s stocks have been trading up by 17.75 percent.

Key Developments on Lantheus Holdings

  • Lantheus sealed a deal to acquire Evergreen Theragnostics for $250M upfront, with potential milestone payments reaching $752.5M. This move is set to enhance its radiopharmaceutical capabilities.

Candlestick Chart

Live Update At 14:31:59 EST: On Wednesday, February 26, 2025 Lantheus Holdings Inc. stock [NASDAQ: LNTH] is trending up by 17.75%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

  • The acquisition aligns with Lantheus’ strategy to scale up manufacturing and push forward the development of OCTEVY, a diagnostic imaging agent currently under FDA review.

  • Despite the cost of the acquisition, Lantheus reaffirms its earnings forecast for 2024, projecting adjusted EPS between $6.65-$6.70 and revenue of $1.51B-$1.52B.

  • Lantheus appoints Dr. Phuong Khanh Morrow to its board to bolster strategic initiatives and drive innovation in oncology therapeutics.

Earnings Snapshot: Solid Groundwork for Growth

As millionaire penny stock trader and teacher Tim Sykes, says, “Preparation plus patience leads to big profits.” This principle is essential in the world of trading, where having a well-thought-out strategy and the discipline to stick with it can lead to substantial financial gains. Traders who take the time to thoroughly analyze market trends and remain patient through market fluctuations are often the ones who see the most success.

Lantheus Holdings reported robust financial figures that underscore its steady trajectory. For the quarter ending Sep 30, 2024, revenue hovered at $1.29B, demonstrating the company’s vitality in the healthcare sector. The stock’s per-share earnings sat comfortably, yet faced slight adjustments due to the acquisition outlay, showing prudence despite large scale expansion.

The company maintained a keen focus on profitability with an EBIT margin of 29.2% and a pretax profit margin of 18.6%. The announcement of maintaining a revenue view of $1.51B-$1.52B reflects sustained confidence in achieving set targets for the year. A look into its financial strength displays sound management with a current ratio of 1.7, affirming its ability to handle liabilities. Asset turnover remained healthy at 0.8, indicating efficient utilization of resources.

More Breaking News

These fundamental insights reveal an organization strengthening its core while laying a foundation for future growth through strategic acquisition.

Stock Insights: Market Response to Strategic Moves

In reviewing Lantheus’ stock movements, one can observe a clear response driven by recent strategic decisions. On Feb 26, 2025, the Lantheus stock opened at $81 and experienced a surge to $96.81, ending the day at $94.26, reflecting market optimism following the acquisition announcement.

Intraday shifts paint a detailed picture of market sentiment and trading behavior. Between 11:00 AM and 11:05 AM, stocks soared from $95.9 to $96, coinciding with news of the acquisition, echoing investor confidence. Meanwhile, key ratios like price-to-earnings at 13.3 and a price-to-sales ratio of 3.72 showcase investor sentiment valuating the stock at its potential, despite the high cost of acquisition.

With strong financials supporting its strategic endeavors, Lantheus appears poised to balance short-term pressures with long-term value creation.

Strategic Moves and Their Potential Impact

The acquisition of Evergreen Theragnostics marks a substantial shift for Lantheus. It signals a commitment to expanding its footprint in the radiopharmaceutical industry, projected to boost its cancer treatment portfolio significantly. This deal comes with scalable manufacturing mechanisms and bolsters Lantheus’ innovative reach with patent-ready diagnostics like OCTEVY.

Dr. Phuong Khanh Morrow’s appointment further supports the strategy by ensuring leadership with a keen eye on research and development. Her role is anticipated to bring enhanced strategic direction in cancer therapeutics, marrying clinical expertise with science-led business acumen.

Investors have shown a positive response to these forward-looking steps. The confidence could manifest further as product approvals materialize, demonstrating the strategic foresight of Lantheus’ leadership.

Future Outlook: Pathways to Sustained Growth

Lantheus Holdings remains a dynamic entity in the medical technology domain. The company’s recent acquisition positions it uniquely to capitalize on emerging trends within oncology diagnostics, offering a pathway to innovation-led growth. Evidence from strategic financial management underlines an agile response to market dynamics, ready to harness technology with tangible outcomes.

Market trends hint at a resilient forecast backed by continued investment into R&D. Experts will be watching how Lantheus manages integration of new assets while maintaining core profitability. Persistent vigilance on operational excellence and market demands will remain crucial.

As Lantheus strides confidently, evolving into a fully integrated player in the radiopharmaceutical landscape, it’s crucial for traders and stakeholders to monitor these developments keenly. As millionaire penny stock trader and teacher Tim Sykes says, “Preparation plus patience leads to big profits.” This trading mindset will be pivotal as Lantheus navigates its growth trajectory. Future quarters will likely reflect the fruition of these efforts, placing Lantheus at the cusp of innovative success.

This content is produced using automated systems designed to deliver timely stock news. All material is reviewed by our editorial team and is provided solely for informational and entertainment purposes. It does not constitute professional investment advice. For additional details, please refer to our [Terms of Service]

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Jack Kellogg

He teaches webinars on Tim Sykes’ Trading Challenge He became Tim’s youngest millionaire student in 2020. Now he’s second on the Trading Challenge leaderboard with $12.9 million in career earnings. He’s a master of the 7-Step Pennystocking Framework. Jack is one of a rare breed of traders to profitably trade the entire penny stock framework.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”

ts swipe photo
Join Thousands Profiting From Smart Trades!
TRADE LIKE TIM

We use cookies to provide you with the best online experience. If you continue browsing, we consider that you accept our Cookie Policy , and also agree to the terms of our Privacy Policy and Terms of Use.